Iniciar sesión Regístrese gratis

Theratechnologies Ingresos Y/Y

¿Qué es el Ingresos Y/Y de Theratechnologies?

El Ingresos Y/Y de Theratechnologies Inc. es 10.25%

¿Cuál es la definición de Ingresos Y/Y?

El crecimiento anual de los ingresos de los últimos 3 años es el crecimiento de los ingresos de un año a otro promediado en los últimos 3 años.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Ingresos Y/Y de compañías en Sector Health Care en NASDAQ en comparadas con Theratechnologies

¿Qué hace Theratechnologies?

theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.

Empresas con ingresos y/y similar a Theratechnologies